showed a trendP=0.036
Treatment with carboplatin and paclitaxel showed a trend towards increasing the risk of complications (OR=1.926, 95% CI: 1.045–3.551, P=0.036).
Treatment with carboplatin and paclitaxel showed a trend towards increasing the risk of complications (OR=1.926, 95% CI: 1.045–3.551, P=0.036).
The adjusted odds ratios for BMI and cancer stage did not reach statistical significance, highlighting the intervention’s primary role in reducing complications.